Matinas BioPharma Holdings, Inc. (MTNB)
ASE – Real Time Price. Currency in USD
0.64
+0.02 (3.15%)
At close: Jun 26, 2026, 4:00 PM EDT
0.61
-0.03 (-4.84%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Find any stock by ticker or company name

ASE – Real Time Price. Currency in USD
0.64
+0.02 (3.15%)
At close: Jun 26, 2026, 4:00 PM EDT
0.61
-0.03 (-4.84%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $2.4M significantly exceed its total debt $1.2M, ensuring strong financial flexibility
Total current assets $2.8M exceed Total current liabilities $2.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.32 | 6.05 | 7.0 | |
| Quick ratio | 1.32 | 5.63 | 7.0 | |
| Debt to Equity | 0.39 | 0.30 | 7.0 | |
| Debt to Assets | 0.20 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 1M | N/A | N/A | N/A |
| Gross Profit | 2M | 155K | -972K | -456K | -407K |
| Operating Income | -25M | -24M | -20M | -7M | -7M |
| Net Income | -21M | -23M | -24M | -11M | -11M |
| EBITDA | -24M | -23M | -19M | -7M | -7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | -51.56 | 50 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -0.46 | N/A | N/A | 3.3 |
| Y/Y | 999 | -15.99 | N/A | 20.23 | 5.5 |
| 3y average | 277.8 | 13.28 | N/A | 10.11 | 6.5 |
| 5y average | 2043.71 | 9.19 | 2.48 | 0.41 | 5.3 |
| Weighted average score | 5.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |